オプションチェーンは、FBS Globalの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、FBS Globalの市場センチメントを評価します。.

FBS Global (NASDAQ:FBGL) 株価情報, オプションチェーン

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial and industrial building projects. As a green contractor focused on environmentally sound practices, It aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, lead lining, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts, sales of construction materials, and rendering of services.

FBS Global Ltd

5 analysts have expressed a variety of opinions on Envista Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVST#NYSE">NVST</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $20.2, a high estimate of $22.00, and a low estimate of $18.00. Surpassing the previous average price target of $19.00, the current average has increased by 6.32%.
<img src="https://www.benzinga.com/files/images/story/2025/1740488494_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The perception of Envista Holdings by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vik Chopra</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$21.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Erin Wright</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$20.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Jason Bednar</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$18.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Glen Santangelo</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$22.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Steven Valiquette</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Underperform</td>
<td>$20.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Envista Holdings. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Envista Holdings compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Envista Holdings's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Envista Holdings's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/NVST/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Envista Holdings analyst ratings.</a>
<h2>All You Need to Know About Envista Holdings</h2>
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products &amp; Technologies and Equipment &amp; Consumables. The company's Specialty Products &amp; Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
<h3>Financial Insights: Envista Holdings</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Envista Holdings displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 1.13%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 0.18%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Envista Holdings's ROE excels beyond industry benchmarks, reaching 0.04%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.02%, the company showcases effective utilization of assets.
Debt Management: Envista Holdings's debt-to-equity ratio is below the industry average. With a ratio of 0.53, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

NVST

Envista Holdings Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

News

Contracts

SYRA

Syra Health Awarded $450,000 Contract Extension With Shelby County Health Department

Needham analyst Ryan MacDonald reiterates Chegg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) from Hold to Hold.

Reiteration

CHGG

Needham Reiterates Hold on Cheggto Hold

In the latest quarter, 4 analysts provided ratings for Artivion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AORT#NYSE">AORT</a>), showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Artivion, revealing an average target of $33.25, a high estimate of $34.00, and a low estimate of $32.00. Experiencing a 1.48% decline, the current average is now lower than the previous average price target of $33.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1740488447_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of Artivion by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mike Matson</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$32.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Mike Matson</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$34.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Daniel Stauder</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$33.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Mike Matson</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$34.00</td>
<td>$34.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Artivion. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Artivion compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Artivion's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Artivion's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AORT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Artivion analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know Artivion Better</h2>
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
<h3>Unraveling the Financial Story of Artivion</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, Artivion showcased positive performance, achieving a revenue growth rate of 9.02% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Artivion's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -2.39% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Artivion's ROE excels beyond industry benchmarks, reaching -0.76%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Artivion's ROA stands out, surpassing industry averages. With an impressive ROA of -0.29%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a high debt-to-equity ratio of 1.19, Artivion faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>What Are Analyst Ratings?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AORT

Breaking Down Artivion: 4 Analysts Share Their Views

DRMA

Dermata Receives Notice Of Acceptance Of Australian Patent Application For DMT410 Program In Treatment Of Hyperhidrosis

Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Riot Platforms, revealing an average target of $18.0, a high estimate of $23.00, and a low estimate of $16.00. Surpassing the previous average price target of $12.50, the current average has increased by 44.0%.
<img src="https://www.benzinga.com/files/images/story/2025/1740488431_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of Riot Platforms's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mike Colonnese</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$17.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>John Todaro</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$16.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Overweight</td>
<td>$23.00</td>
<td>-</td>
</tr>
<tr>
<td>Reginald Smith</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$16.00</td>
<td>$9.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Riot Platforms. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Riot Platforms compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Riot Platforms's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Riot Platforms's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/RIOT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Riot Platforms analyst ratings.</a>
<h2>Unveiling the Story Behind Riot Platforms</h2>
Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining; Data Center Hosting and Engineering. It generates maximum revenue from the Bitcoin Mining segment which generates revenue from the Bitcoin the company earns through its mining activities.
<h3>Riot Platforms's Financial Performance</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Riot Platforms's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 63.39%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Riot Platforms's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -182.06%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Riot Platforms's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -5.79%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -5.47%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Riot Platforms's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.01.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RIOT

Riot Platforms Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

In the current market session, Alcoa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) stock price is at $34.88, after a 0.40% drop. However, over the past month, the company's stock spiked by 2.55%, and in the past year, by 33.05%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1740488421_0.png" alt="Past Year Chart" />

<h3>How Does Alcoa P/E Compare to Other Companies?</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 23.38 in the Metals &amp; Mining industry, Alcoa Inc. has a higher P/E ratio of 134.69. Shareholders might be inclined to think that Alcoa Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1740488421_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

A Look Into Alcoa Inc's Price Over Earnings

Needham analyst David Saxon reiterates Envista Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVST#NYSE">NVST</a>) from Hold to Hold.

Needham Reiterates Hold on Envista Holdingsto Hold

Citigroup analyst Arthur Truslove maintains UL Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ULS#NYSE">ULS</a>) with a Buy and raises the price target from $60 to $60.5.

Price Target

Citigroup Maintains Buy on UL Solutions, Raises Price Target to $60.5

HC Wainwright &amp; Co. analyst Andrew Fein reiterates BioCryst Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCRX#NASDAQ">BCRX</a>) with a Buy and maintains $30 price target.

BCRX

HC Wainwright & Co. Reiterates Buy on BioCryst Pharma, Maintains $30 Price Target

Marks the 3rd Mobilicom datalink to be added to the approved short list of products in the Blue UAS program designed to secure commercial UAS technology for the Department of Defense

Mobilicom Expands Its Blue UAS Portfolio With Latest DoD-Approved Secure Drone Communication Solution

While European defense stocks soar, <a href="https://benzinga.com/topic/aerospace-defense-stocks" target="_blank" rel="noreferrer noopener">their American counterparts</a> are stuck in the trenches. 
As <a href="https://www.ft.com/content/1ea4a5d6-c8a9-4a87-8e3a-9a7c084d1a77">reported</a> by the Financial Times, President Donald Trump&#8216;s renewed calls for Europe to shoulder its own security burden paired with plans to trim Pentagon spending have clipped the wings of U.S. defense giants.
<h2 class="wp-block-heading">Europe&#8217;s Defense Boom, America&#8217;s Bust</h2>
Shares of Germany&#8217;s Rheinmetall have skyrocketed nearly 40% since Trump's return to the White House, while South Korea's Hanwha Aerospace has surged more than 70%, fueled by NATO rearmament deals. 
Meanwhile, American stalwarts like Lockheed Martin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) and Northrop Grumman Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) are down 13% and 10.8%, respectively, as fears of shrinking Pentagon contracts weigh on investor sentiment.
Read Also: <a href="https://www.benzinga.com/tech/25/02/43899444/trump-moves-to-impose-tariffs-on-countries-with-digital-taxes-defending-apple-amazon-meta-google-and-other-us-tech-giants">Trump Moves To Impose Tariffs On Countries With Digital Taxes, Defending Apple, Amazon, Meta, Google And Other US Tech Giants</a>
<h2 class="wp-block-heading">Winners &amp; Losers Stateside</h2>
Among the top U.S. players, Lockheed Martin (-13%) and Northrop Grumman (-10.8%) have taken the biggest hits, while Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) stands out as the lone gainer, up 2.5% since Trump took office. 
RTX Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) (-0.25%) has held relatively steady, but General Dynamics Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) (-9.3%) and L3Harris Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) (-10.3%) have also faced notable declines.
<h2 class="wp-block-heading">Investor Implications: Pivot Or Persevere?</h2>
For investors, the message is clear: follow the money and it&#8217;s heading across the Atlantic.
With European defense budgets ballooning and the US tightening its belt, ETFs like iShares MSCI Europe ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEUR#NYSE">IEUR</a>) and SPDR S&amp;P Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XAR#NYSE">XAR</a>) might offer better short-term returns than their U.S.-heavy counterparts.
Unless U.S. defense contractors can secure new international contracts or navigate domestic budget cuts, their stocks may remain stuck in neutral while European rivals continue their ascent.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/02/43828189/4-etfs-in-the-crosshairs-as-defense-cuts-loom-is-it-time-to-play-offense">4 ETFs In The Crosshairs As Defense Cuts Loom — Is It Time To Play Offense?</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Trading Ideas

IEUR

US Defense Stocks Stumble As Trump's Pentagon Cuts Fuel European Surge

Needham analyst Mike Matson maintains Artivion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AORT#NYSE">AORT</a>) with a Buy and lowers the price target from $34 to $32.

Needham Maintains Buy on Artivion, Lowers Price Target to $32

Citigroup analyst Tyler Radke maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Buy and raises the price target from $225 to $230.

SNOW

Citigroup Maintains Buy on Snowflake, Raises Price Target to $230

Citigroup analyst Fatima Boolani maintains Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) with a Buy and raises the price target from $205 to $220.

PANW

Citigroup Maintains Buy on Palo Alto Networks, Raises Price Target to $220

Evercore ISI Group analyst Umer Raffat initiates coverage on Metsera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) with a Outperform rating.

Initiation

MTSR

Evercore ISI Group Initiates Coverage On Metsera with Outperform Rating

LASE

Laser Photonics Expands R&D In High-Precision Laser Marking For Stainless Steel Medical Wires

Needham analyst Quinn Bolton reiterates Navitas Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) with a Buy and maintains $4 price target.

NVTS

Needham Reiterates Buy on Navitas Semiconductor, Maintains $4 Price Target

MoneyLion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ML#NYSE">ML</a>) reported quarterly earnings of $0.76 per share which beat the analyst consensus estimate of $0.58 by 31.03 percent. This is a 330.3 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $158.59 million which beat the analyst consensus estimate of $149.51 million by 6.07 percent. This is a 40.39 percent increase over sales of $112.96 million the same period last year.

Earnings

Earnings Beats

MoneyLion Q4 EPS $0.76 Beats $0.58 Estimate, Sales $158.59M Beat $149.51M Estimate

Lowe&#8217;s Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) will release its fourth-quarter financial results before the opening bell <a href="https://www.benzinga.com/insights/news/25/02/43746164/heres-how-much-1000-invested-in-lowes-companies-20-years-ago-would-be-worth-today">on Wednesday, Feb. 26</a>.
Analysts expect the Mooresville, North Carolina-based company to report quarterly earnings at $1.84 per share, up from $1.77 per share in the year-ago period. Lowe&#8217;s projects quarterly revenue of $18.29 billion, compared to $18.6 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Feb. 20, Telsey Advisory Group analyst Joseph Feldman maintained Lowe&#8217;s with an Outperform rating and maintained a $305 price target.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43166746/home-depot-likely-to-outcomp-lowes-in-q4-analyst-says-as-home-improvement-battle-heads-toward-earnings">Home Depot &#8216;Likely To Outcomp&#8217; Lowe&#8217;s In Q4, Analyst Says As Home Improvement Battle Heads Toward Earnings</a>
With the recent buzz around Lowe&#8217;s, some investors may be eyeing potential gains from the company's dividends too. As of now, the retailer offers an annual dividend yield of 1.92%, which is a quarterly dividend amount of $1.15 per share ($4.60 a year).
To figure out how to earn $500 monthly from Lowe&#8217;s, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by Lowe&#8217;s $4.60 dividend: $6,000 / $4.60 = 1,304 shares.
So, an investor would need to own approximately $309,152 worth of Lowe&#8217;s, or 993 shares to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $4.60 = 261 shares, or $61,878 to generate a monthly dividend income of $100.
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, impacting the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, the dividend yield will decrease if a company decreases its dividend payment.
Price Action: Shares of Lowe&#8217;s fell by 0.8% to close at $237.21 on Monday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43909562/top-2-industrials-stocks-that-are-set-to-fly-this-quarter">Top 2 Industrials Stocks That Are Set To Fly This Quarter</a></li>
</ul>
Image: Shutterstock

How To Earn $500 A Month From Lowe's Stock Ahead Of Q4 Earnings

Press Releases

FBS Global Limited Announces Pricing of Initial Public Offering

Offerings

WallachBeth Announces Pricing Of FBS Global Initial Public Offering

FBS Global Limited Announces Closing of Initial Public Offering

WallachBeth Capital Announces Closing Of FBS Global LTD Initial Public Offering

FBGL

FBS Global

Founder Group

HUHUTECH International Group Inc. - Ordinary Shares

HUHUTECH International Gr

Ming Shing Group Holdings Limited - Ordinary Shares

Ming Shing Group Holdings

Nocera

OneConstruction Group Limited - Ordinary Shares

OneConstruction Group

Orion Gr Hldgs

Safe & Green Holdings Corp. - Common Stock

Safe & Green Holdings

Shimmick

Skyline Builders Group Holding Limited - Class A Ordinary Shares

Skyline Builders Group

SKK Holdings

Southland Holdings

Emeren Group Ltd American Depositary Shares, each representing 10 shares

Comments

FBS Global

FBS Global (FBGL) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル